Floatz logo

Etoposide

Cancer Of Unknown Primary Site

University of California, DavisSmall moleculePhase 2/3Dormant
BBB
73/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
65/ 100
Competitive Position
89/ 100

Competitive context

18 Active assets in the Cancer Of Unknown Primary Site cohort.

Asset / SponsorPhaseRating
Amifostine
M.D. Anderson Cancer Center
Phase 4BBB
NEPENTHE
M.D. Anderson Cancer Center
Phase 4BBB
Dexasone
Alliance for Clinical Trials in Oncology
Phase 3BBB
Sargramostim
Barbara Ann Karmanos Cancer Institute
Phase 2BBB
Xaliplatin
Alliance for Clinical Trials in Oncology
Phase 2BBB

View all 50 →

Same molecule, other indications

Etoposide is also rated in:

acute megakaryoblastic leukemiaDormant
BBB
Indicative · Phase 3
79 / 100
View asset →
acute monocytic leukemiaDormant
BBB
Indicative · Phase 3
79 / 100
View asset →
acute myeloblastic leukemia with maturationDormant
BBB
Indicative · Phase 3
79 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →